- Home
- HIHO vs IMRN Comparison
HIHO vs IMRN Comparison
Compare HIHO & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIHO
- IMRN
- Stock Information
- Founded
- HIHO 1990
- IMRN 1994
- Country
- HIHO Hong Kong
- IMRN Australia
- Employees
- HIHO N/A
- IMRN N/A
- Industry
- HIHO Industrial Machinery/Components
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- HIHO Industrials
- IMRN Health Care
- Exchange
- HIHO Nasdaq
- IMRN Nasdaq
- Market Cap
- HIHO 8.3M
- IMRN 9.2M
- IPO Year
- HIHO 1996
- IMRN N/A
- Fundamental
- Price
- HIHO $1.71
- IMRN $1.74
- Analyst Decision
- HIHO
- IMRN Strong Buy
- Analyst Count
- HIHO 0
- IMRN 1
- Target Price
- HIHO N/A
- IMRN $5.00
- AVG Volume (30 Days)
- HIHO 7.8K
- IMRN 24.7K
- Earning Date
- HIHO 07-31-2025
- IMRN 07-07-2025
- Dividend Yield
- HIHO 7.02%
- IMRN N/A
- EPS Growth
- HIHO N/A
- IMRN N/A
- EPS
- HIHO N/A
- IMRN N/A
- Revenue
- HIHO $7,345,000.00
- IMRN $4,048,286.00
- Revenue This Year
- HIHO N/A
- IMRN N/A
- Revenue Next Year
- HIHO N/A
- IMRN N/A
- P/E Ratio
- HIHO N/A
- IMRN N/A
- Revenue Growth
- HIHO 11.36
- IMRN 82.90
- 52 Week Low
- HIHO $1.40
- IMRN $1.50
- 52 Week High
- HIHO $2.88
- IMRN $2.87
- Technical
- Relative Strength Index (RSI)
- HIHO 42.85
- IMRN 58.70
- Support Level
- HIHO $1.64
- IMRN $1.68
- Resistance Level
- HIHO $1.77
- IMRN $1.94
- Average True Range (ATR)
- HIHO 0.04
- IMRN 0.09
- MACD
- HIHO -0.01
- IMRN 0.02
- Stochastic Oscillator
- HIHO 33.33
- IMRN 76.92
About HIHO Highway Holdings Limited
Highway Holdings Ltd is a holding company. The company is a manufacturer of metal, plastic, electric and electronic components for original equipment manufacturers (OEM) and contract manufacturers. Its operating segment includes Metal stamping and mechanical OEM and Electric OEM. The metal stamping segment focuses on the manufacturing and sale of metal parts and components. The company generates maximum revenue from the Metal stamping and mechanical OEM segment. Geographically, it derives a majority of its revenue from Europe and also has a presence in Hong Kong and China, North America, and Other Asian countries.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.